✦ LIBER ✦

1076 Phase II study of topotecan in patients with squamous cell carcinoma of the lung previously untreated with chemotherapy

✍ Scribed by Perez-Soler, R.; Fossella, Frank V.; Murphy, William K.; Glisson, Bonnie S.; Lee, Jin Soo; Hong, Waun K.

Book ID: 124133146
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 150 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)96323-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of 10-EdAM in patients wi

Phase II study of 10-EdAM in patients with squamous cell carcinoma of the head and neck, previously untreated with chemotherapy

✍ Michael D. Green; Peter Sherman; John Zalcberg 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 310 KB

Phase II study of carboplatin in previou

Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Phase II study of trimetrexate in previo

Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma

✍ Walter H. Harvey; Thomas R. Fleming; Phyllis J. Goodman; Janice H. Harvey; Saul 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 152 KB

Phase II studies of topotecan in patient

Phase II studies of topotecan in patients with non-small cell lung cancer (NSCLC) previously untreated and patients with small cell lung (SCLC) cancer refractory to etoposide

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Phase II study of daunorubicin in previo

Phase II study of daunorubicin in previously untreated patients with advanced colorectal carcinoma

✍ Harvey, J. ;Bonnem, E. ;Grady, K. ;Goodman, A. ;Schein, P. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Fourteen patients with advanced measurable colorectal cancer were treated with daunorubicin hydrochloride (DNR). The drug was administered at a dose of 15 mg/m2 on day 1 through 3 and 8 through 10. After a Cday rest period DNR was given in weekly injections of 15 mg/m2. There were no partial or comp

A Phase II trial of topotecan and gemcit

A Phase II trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma

✍ David A. Rinaldi; Nancy A. Lormand; Joseph E. Brierre; James L. Cole; Brian C. B 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 2 views

## Abstract ## BACKGROUND Multiple trials have been performed to evaluate second‐line clinical chemotherapy in patients with advanced nonsmall cell lung carcinoma (NSCLC). However, no single agent or combination has demonstrated superior activity. ## METHODS Patients with advanced NSCLC who had